Todd Miller

In vivo antitumor activity of SU11248, a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor and platelet-derived growth factor receptors: determination of a pharmacokinetic/pharmacodynamic relationship.

Dirk B. Mendel, Alexander Laird, Xiaohua Xin et al. · PubMed · 2003 · 2K citations

Tumor Xenografts, Mouse Xenograft Models, Active Dose +18

Discovery of 5-[5-Fluoro-2-oxo-1,2- dihydroindol-(3<i>Z</i>)-ylidenemethyl]-2,4- dimethyl-1<i>H</i>-pyrrole-3-carboxylic Acid (2-Diethylaminoethyl)amide, a Novel Tyrosine Kinase Inhibitor Targeting Vascular Endothelial and Platelet-Derived Growth Factor Receptor Tyrosine Kinase

Li Sun, Chris Liang, Sheri Shirazian et al. · Journal of Medicinal Chemistry · 2003 · 518 citations · Full text

Chemoprevention Strategy, Weakly Basic Analogues, Pharmacotherapy +20

Potent and selective inhibitors of the Met [hepatocyte growth factor/scatter factor (HGF/SF) receptor] tyrosine kinase block HGF/SF-induced tumor cell growth and invasion.

Xueyan Wang, Phuong Le, Congxin Liang et al. · PubMed · 2003 · 114 citations

Pathology, Selective Inhibitors, Tumor Biology +16

Reaction classification and retrieval. A linkage between synthesis generation and reaction databases

James B. Hendrickson, Todd Miller · Journal of the American Chemical Society · 1991 · 20 citations

Engineering, Databases, Altmetric Attention Score +24

Reaction indexing for reaction databases

James B. Hendrickson, Todd Miller · Journal of Chemical Information and Computer Sciences · 1990 · 14 citations

Engineering, Databases, Media Standards +21